asa guidelines for glp 1 drugs How should we approach patients on GLP-1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the and Decoding the Enigma: Strategies Anesthetic Management of Patients on Glucagon-Like Mapping the effectiveness and risks
Description
Metabolic response Retatrutides activity at GIP and glucagon receptors may be one reason researchers are interested in its broader metabolic profile
I love the fact that youre trying and youre now motivating me
Incretin-based therapies for obesity treatment
Ghrelin Acts in the Central Nervous System to Stimulate Gastric Acid Secretion
The significance of these effects is unknown
Individuals with obesity have increased risk for heart disease, stroke, type 2 diabetes and kidney disease as well as several types of cancer
